MedPath

Effect of Dexametasone in ovarian response in PCOs women in IVF

Phase 2
Conditions
Condition 1: Polycystic ovarian. Condition 2: Infertility.
Polycystic ovarian syndrome
Female infertility associated with anovulation
Registration Number
IRCT201108174306N4
Lead Sponsor
Vice chancellor of Technology and Research, Babol University of Medical Science
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Complete
Sex
Female
Target Recruitment
100
Inclusion Criteria

infertile PCOS women candidate for the first cycle of ICSI, 20-35 yrs with infertility duration <5yrs.
All patients with uterus abnormalities like myoma, intra uterine septum , women with endometriuma, allergy background to dexamethasone and hyperstimulation syndrome (OHSS) is excluded

Exclusion Criteria

Not provided

Study & Design

Study Type
interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Rate of dominant follicle. Timepoint: 12-16 days after ovulation day. Method of measurement: Number.
Secondary Outcome Measures
NameTimeMethod
Rate of retrieved oocytes. Timepoint: 12-16 days after mensturation. Method of measurement: Number.;Fertilization rate. Timepoint: 16-18 days after mensturation. Method of measurement: number.;Abortion rate. Timepoint: 25-30 days after embryo transfer. Method of measurement: number.
© Copyright 2025. All Rights Reserved by MedPath